Theoretical considerations for the ideal aromatase inhibitor
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.springerlink.com/index/pdf/10.1023/A:1006088405721
Reference27 articles.
1. Schwarzel W, Kruggel WG, Brodie HJ: Studies on the mechanism of estrogen biosynthesis VIII. The development of inhibitors of the enzyme system in human placenta. Endocrinology 92: 866–880, 1973
2. Stuart-Harris R, Smith IE: Aminoglutethimide in the treatment of advanced breast cancer. Cancer Treat Rev 11: 189–204, 1984
3. Dowsett M: Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer. J Steroid Biochem 37: 1037–1041, 1990
4. Buzdar A, Howell A, Jones SE, Blomqvist C, Vogel CL, Eiermann W, Walter JM, Azab M, Webster A, Plourde PV, for the Arimidex Group: Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: Results of overview analysis of two phase III trials. J Clin Oncol 14: 2000–2011, 1996
5. Smith I, Dombernowsky P, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin A, Gudgeon A, Chaudri HA, Homberger U: Double-blind trial in postmenopausal (PMP) women with advanced breast cancer (ABC) showing a dose-effect and superiority of 2.5 mg letrozole over megestrol acetate (MA). Eur J Cancer 32A(Suppl 2): 49, 1996
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and optimization of nanoemulsion containing exemestane using box-behnken design;Journal of Drug Delivery Science and Technology;2023-02
2. A comprehensive review on novel delivery approaches for exemestane;Journal of Drug Delivery Science and Technology;2022-09
3. Adsorption Behavior of Aromasin onto C20 and C24 Nano-Cages: Density Functional Theory Study;Russian Journal of Inorganic Chemistry;2020-12
4. Targeting protein quality control pathways in breast cancer;BMC Biology;2017-11-16
5. Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics;Cancer Nanotechnology;2013-04-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3